Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Westerweel

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
European Heart Journal|October 1, 2008
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapyPeter E Westerweel, Frank L J Visseren, Gideon R Hajer, et al.
Cardiovascular Diabetology|September 23, 2010
Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse modelPeter E Westerweel, Cindy T J van Velthoven, Tri Q Nguyen, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 7, 2013
Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsyHugo J A Adams, Thomas C Kwee, Henk M Lokhorst, et al.
Journal of Medical Internet Research|May 16, 2020
The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development ApproachGeneviève Icg Ector, Peter E Westerweel, Rosella Pmg Hermens, et al.
Haematologica|September 2, 2017
Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemiaInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
European Journal of Haematology|July 12, 2024
Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patientsCamille Kockerols, Peter J M Valk, Jeroen J W M Janssen, et al.
Leukemia & Lymphoma|August 30, 2017
Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvementLaura S Hiemcke-Jiwa, Roos J Leguit, Joyce H Radersma-van Loon, et al.
The Oncologist|July 21, 2022
Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with CancerHánah N Rier, Marieke C Meinardi, Joost van Rosmalen, et al.
European Journal of Haematology|December 31, 2017
Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safeInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
Haematologica|March 23, 2023
High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient populationCamille C B Kockerols, Inge G P Geelen, Mark-David Levin, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
European Heart Journal|October 1, 2008
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapyPeter E Westerweel, Frank L J Visseren, Gideon R Hajer, et al.
Cardiovascular Diabetology|September 23, 2010
Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse modelPeter E Westerweel, Cindy T J van Velthoven, Tri Q Nguyen, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 7, 2013
Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsyHugo J A Adams, Thomas C Kwee, Henk M Lokhorst, et al.
Journal of Medical Internet Research|May 16, 2020
The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development ApproachGeneviève Icg Ector, Peter E Westerweel, Rosella Pmg Hermens, et al.
Haematologica|September 2, 2017
Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemiaInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
European Journal of Haematology|July 12, 2024
Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patientsCamille Kockerols, Peter J M Valk, Jeroen J W M Janssen, et al.
Leukemia & Lymphoma|August 30, 2017
Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvementLaura S Hiemcke-Jiwa, Roos J Leguit, Joyce H Radersma-van Loon, et al.
The Oncologist|July 21, 2022
Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with CancerHánah N Rier, Marieke C Meinardi, Joost van Rosmalen, et al.
European Journal of Haematology|December 31, 2017
Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safeInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
Haematologica|March 23, 2023
High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient populationCamille C B Kockerols, Inge G P Geelen, Mark-David Levin, et al.
Pageof 11